Covalent modification by isoprenoid lipids (prenylation) is an important component in the localization and activity of many proteins involved in cellular signaling. The majority of prenylated proteins belong to a group of proteins tenned """"""""CaaX proteins"""""""" that are defined by a specific C terminal motif that directs their modification. CaaX prenyl proteins, which include most members oi the Ras family of GTP-binding proteins (0 proteins), play critical roles in a number of cellular processes, including transmembrane signaling, intracellular membrane trafficking, and oncogenesis. The long-term goals of this research project have been to elucidate the biochemistry of protein prenylation. This initially involved identification of the two enzymes, termed CaaX prenyltransferases, responsible for the modification. Work on these enzymes, protein farnesyltransferase (FTase) and protein geranylgeranyltransferase type I (GGTase-I), has now moved into detailed structure-function analyses guided by the emerging structural information. A mammalian CaaX protease, termed Rce1, has been identified and shown to be responsible for the post-prenylation processing of all Ras isoforms and many other CaaX proteins. A Rce1 knockout mouse has been generated, and studies on cells derived from the mice indicate that Ras function is impaired if the proteolysis step is blocked. A detailed characterization of Rce1 is being undertaken that focuses on defining the catalytic mechamsn and membrane topology of the enzyme. A novel splice variant of Rce1, Rce1B, is also being studied to determine if the two variants play distinct roles in CaaX proteolysis. A lysosomal enzyme tha degrades specific prenylcysteines produced during metabolic turnover of prenyl proteins has been identified. This enzyme, termed prenylcysteine lyase (PCLase), utilizes an unusual oxidative mechanism to cleave thioether bonds. Cell-based systems wifi be developed to directly test the hypothesis that PCLase plays a critical role in the cellular metabolism of prenylcysteines. Continuec elucidation of the molecular mechanisms of protein prenylation should greatly facilitate investigations into the importance of this process in cellular signaling events and oncogenesis.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM046372-10
Application #
6625873
Study Section
Physiological Chemistry Study Section (PC)
Program Officer
Ikeda, Richard A
Project Start
1993-08-01
Project End
2006-03-31
Budget Start
2003-04-01
Budget End
2004-03-31
Support Year
10
Fiscal Year
2003
Total Cost
$348,040
Indirect Cost
Name
Duke University
Department
Pharmacology
Type
Schools of Medicine
DUNS #
044387793
City
Durham
State
NC
Country
United States
Zip Code
27705
Mizrahi, Ariel; Berdichevsky, Yevgeny; Casey, Patrick J et al. (2010) A prenylated p47phox-p67phox-Rac1 chimera is a Quintessential NADPH oxidase activator: membrane association and functional capacity. J Biol Chem 285:25485-99
Cushman, Ian; Casey, Patrick J (2009) Role of isoprenylcysteine carboxylmethyltransferase-catalyzed methylation in Rho function and migration. J Biol Chem 284:27964-73
Peterson, Yuri K; Wang, Xiang S; Casey, Patrick J et al. (2009) Discovery of geranylgeranyltransferase-I inhibitors with novel scaffolds by the means of quantitative structure-activity relationship modeling, virtual screening, and experimental validation. J Med Chem 52:4210-20
Ugolev, Yelena; Berdichevsky, Yevgeny; Weinbaum, Carolyn et al. (2008) Dissociation of Rac1(GDP).RhoGDI complexes by the cooperative action of anionic liposomes containing phosphatidylinositol 3,4,5-trisphosphate, Rac guanine nucleotide exchange factor, and GTP. J Biol Chem 283:22257-71
Katadae, Maiko; Hagiwara, Ken'ichi; Wada, Akimori et al. (2008) Interacting targets of the farnesyl of transducin gamma-subunit. Biochemistry 47:8424-33
Rao, P Vasantha; Peterson, Yuri K; Inoue, Toshihiro et al. (2008) Effects of pharmacologic inhibition of protein geranylgeranyltransferase type I on aqueous humor outflow through the trabecular meshwork. Invest Ophthalmol Vis Sci 49:2464-71
Leow, Jo-Lene; Baron, Rudi; Casey, Patrick J et al. (2007) Quantitative structure-activity relationship (QSAR) of indoloacetamides as inhibitors of human isoprenylcysteine carboxyl methyltransferase. Bioorg Med Chem Lett 17:1025-32
Sjogren, Anna-Karin M; Andersson, Karin M E; Liu, Meng et al. (2007) GGTase-I deficiency reduces tumor formation and improves survival in mice with K-RAS-induced lung cancer. J Clin Invest 117:1294-304
Baron, Rudi A; Peterson, Yuri K; Otto, James C et al. (2007) Time-dependent inhibition of isoprenylcysteine carboxyl methyltransferase by indole-based small molecules. Biochemistry 46:554-60
Peterson, Yuri K; Kelly, Patrick; Weinbaum, Carolyn A et al. (2006) A novel protein geranylgeranyltransferase-I inhibitor with high potency, selectivity, and cellular activity. J Biol Chem 281:12445-50

Showing the most recent 10 out of 57 publications